apnimed.comHealthcareFounded: 2017Funding to Date: $128.27MM
Apnimed is a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related disorders.
View Enterprise Value for Apnimed.